Putting the patient at the centre of cancer-associated thrombosis treatment decisions
30 Apr 2015
Putting the patient at the centre of cancer-associated thrombosis treatment decisions
Dual mTOR inhibition effective in reducing tumour load in CLL
Positive results in phase II study of copanlisib treating NHL and CLL
Inside cancer - public lecture
Pembrolizumab showed clinical benefit in malignant pleural mesothelioma
Latest trials and outcomes with new CLL treatments
Developing treatments for indolent non hodgkin lymphoma
The evolution of CLL treatment
How to decide the treatment of CLL in 2015
Developments in immunotherapy
Putting adoptive T cell therapy on the path to regulatory approval
Radiogenomic evaluation of tumour response to targeted agents